Viewing Study NCT00961220


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-02-03 @ 5:52 AM
Study NCT ID: NCT00961220
Status: COMPLETED
Last Update Posted: 2018-05-22
First Post: 2009-08-16
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma View
None Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7 View
None Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7 View
Keywords: